Crossmark

Multiple-day administration of fosaprepitant combined with tropisetron and olanzapine improves the prevention of nausea and vomiting in patients receiving chemotherapy prior to autologous hematopoietic stem cell transplant: a retrospective study

Crossref DOI link: https://doi.org/10.1007/s00277-022-04877-w

Published Online: 2022-06-06

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ye, Peipei

Pei, Renzhi

Wang, Tiantian

Cao, Junjie

Zhang, Pisheng

Chen, Dong

Liu, Xuhui

Du, Xiaohong

Li, Shuangyue

Tang, Shanhao

Hu, Youqian

Jiang, Lei https://orcid.org/0000-0002-8676-8859
Lu, Ying
License Information

Text and Data Mining valid from 2022-06-06

Version of Record valid from 2022-06-06
More Information

Article History

Received: 21 November 2021

Accepted: 29 May 2022

First Online: 6 June 2022

Declarations

:

: The study protocol is in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards, and was approved by the Research Ethics Committee of The Affiliated People’s Hospital of Ningbo University.

: Written informed consent was obtained from all individual participants included in the current study.

: Participants signed informed consent regarding publishing their data.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below